Unknown PHASE1 INTERVENTIONAL 3-arm NCT03017248

Low-dose Ketamine for Acute Pain in the Emergency Department

Benefit of the Association of Low Doses of Ketamine With Intravenous Morphine in the Treatment of Acute Severe Pain in Emergency Department

Sponsor: Faculty of Medicine, Sousse

Conditions Pain

Interventions Ketamine Morphine Placebos

Updated 6 times since 2017 Last updated: Jan 29, 2017 Started: Jan 31, 2016 Primary completion: Jun 30, 2016 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Pain, this trial is ongoing. The trial is conducted by Faculty of Medicine, Sousse and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Feb 2019 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Active Not Recruiting → Unknown Status
Jun 2018 — Feb 2019 [monthly]

Active Not Recruiting PHASE1

▶ Show 1 earlier version

Feb 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE1

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Faculty of Medicine, Sousse

Data source: Faculty of Medicine, Sousse

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sousse, Tunisia